Free Trial
NASDAQ:CYRX

Cryoport (CYRX) Stock Price, News & Analysis

Cryoport logo
$4.70 -1.53 (-24.56%)
Closing price 03/10/2025 04:00 PM Eastern
Extended Trading
$4.72 +0.02 (+0.51%)
As of 03/10/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cryoport Stock (NASDAQ:CYRX)

Key Stats

Today's Range
$4.65
$6.41
50-Day Range
$4.80
$8.82
52-Week Range
$4.58
$20.11
Volume
1.41 million shs
Average Volume
534,087 shs
Market Capitalization
$232.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.29
Consensus Rating
Moderate Buy

Company Overview

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Remove Ads

Cryoport Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

CYRX MarketRank™: 

Cryoport scored higher than 46% of companies evaluated by MarketBeat, and ranked 89th out of 129 stocks in the transportation sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cryoport has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cryoport has only been the subject of 2 research reports in the past 90 days.

  • Read more about Cryoport's stock forecast and price target.
  • Earnings Growth

    Earnings for Cryoport are expected to decrease in the coming year, from ($0.99) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cryoport is -1.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cryoport is -1.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cryoport has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cryoport's valuation and earnings.
  • Percentage of Shares Shorted

    4.36% of the float of Cryoport has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryoport has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in Cryoport has recently increased by 3.48%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Cryoport does not currently pay a dividend.

  • Dividend Growth

    Cryoport does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.36% of the float of Cryoport has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryoport has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in Cryoport has recently increased by 3.48%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Cryoport has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Transportation companies.
  • News Coverage This Week

    MarketBeat has tracked 24 news articles for Cryoport this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    1 people have added Cryoport to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cryoport insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.10% of the stock of Cryoport is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    92.90% of the stock of Cryoport is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cryoport's insider trading history.
Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Stock News Headlines

Roth Capital Predicts Cryoport's Q1 Earnings (NASDAQ:CYRX)
The real reason gold is soaring (and likely to continue)
Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett’s insights show you how to position yourself for wealth in 2025. Don’t wait—these opportunities can disappear fast!
CryoPort trading halted, volatility trading pause
Cryoport sees FY25 revenue $240M-$250M, consensus $244.96M
Roth MKM Sticks to Their Buy Rating for CryoPort (CYRX)
See More Headlines

CYRX Stock Analysis - Frequently Asked Questions

Cryoport's stock was trading at $7.78 at the start of the year. Since then, CYRX stock has decreased by 39.6% and is now trading at $4.70.
View the best growth stocks for 2025 here
.

Cryoport, Inc. (NASDAQ:CYRX) issued its quarterly earnings results on Tuesday, March, 4th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.33) by $0.09. The firm earned $59.53 million during the quarter, compared to the consensus estimate of $58.71 million. Cryoport had a negative net margin of 70.08% and a negative trailing twelve-month return on equity of 13.35%.

Cryoport's board authorized a stock buyback plan on Tuesday, August 6th 2024, which authorizes the company to repurchase $200,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 49.1% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its stock is undervalued.

Cryoport's top institutional shareholders include Cadian Capital Management LP (9.97%), Millennium Management LLC (8.38%), Vanguard Group Inc. (5.53%) and Fred Alger Management LLC (5.19%). Insiders that own company stock include Jerrell Shelton, Robert Stefanovich, Richard J Berman, Mark W Sawicki, Edward J Zecchini, Ramkumar Mandalam and Robert J Hariri.
View institutional ownership trends
.

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cryoport investors own include American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Humana (HUM).

Company Calendar

Last Earnings
3/04/2025
Today
3/10/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYRX
Employees
1,170
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.29
High Stock Price Target
$17.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+159.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-99,590,000.00
Pretax Margin
-70.13%

Debt

Sales & Book Value

Annual Sales
$228.39 million
Cash Flow
$0.28 per share
Price / Cash Flow
16.95
Book Value
$9.45 per share
Price / Book
0.50

Miscellaneous

Free Float
44,438,000
Market Cap
$234.30 million
Optionable
Optionable
Beta
1.67

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:CYRX) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners